benefits of microdosing glp-1 Microdosing, Brain Health & Alzheimer's Prevention Let's talk about “microdosing” GLP-1s
Description
It is being investigated for treatment of various heterozygous mutations in LepR, POMC, or PCSK1 genes, and homozygous or heterozygous mutations in the steroid receptor coactivator-1 (SRC1) or SH2B adapter protein 1 (SH2B1) genes (125)
[1][2] Experts warn that non-approved compounds might contain impurities, incorrect concentrations, or additives that pose risks
Combining these medications is generally not recommended without explicit guidance from a specialist
Baseline characteristics of the included studies are summarised in Table 1
In October 2024, Amneal Pharma invested Rs 1,600 crore in Gujarat to manufacture GLP-1 drugs
It impacts several body systems, including the brain, pancreas, and gut
